Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Automatic Data Capture (ADC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...
Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), licensed its ADC technology to BigHat Biosciences ...
A new family of microcontrollers (MCUs) —the PIC24FJ128GC010 -- is an analog system on chip that integrates an on-chip precision 16-bit ADC and 10 Msps 12-bit ADC, plus a DAC and dual operational ...
Collaboration underscores Lonza's commitment to helping customers deliver innovative new therapies to patients by offering a comprehensive service offering for differentiated ADCs BigHat's artificial ...
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza’s commitment to helping customers deliver ...
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studies Collaboration underscores Lonza's commitment to helping customers deliver ...